World Generic Medicines Europe Congress attracts attendees from leading generic pharma manufacturers, investment banks, pharmaceutical wholesale, law firms and API manufacturers to discuss the latest developments in the generics industry.
World Generic Medicines Congress Europe 2012
Home/Conferences
|
Posted 27/01/2012
0
Post your comment
World Generics Medicines Congress Europe 2012
28 February–2 March 2012
London, UK
For more information, see:
http://www.healthnetworkcommunications.com/2012/world-generic-medicines-congress-europe/
Guidelines
FDA issues guidance on AI use in drug and biologicals regulatory decision making
ICH adopts Good Clinical Practice Guideline for clinical trials
Policies & Legislation
NPRA Malaysia trials new timelines for variation applications
Regulatory evolution and impact of simplified requirements for interchangeable biosimilars in the US
Related content
ASBM/GaBI 2024 webinar on BIOSIMILAR RED TAPE ELIMINATION ACT (S2305)
Home/Conferences Posted 05/11/2024
ASBM/GaBI 2023 webinar on INTERCHANGEABILITY DESIGNATION FOR BIOSIMILARS
Home/Conferences Posted 12/12/2023
Most viewed articles
The best selling biotechnology drugs of 2008: the next biosimilars targets
Post your comment